ATE334203T1 - Verfahren zur herstellung von sekundären metaboliten - Google Patents

Verfahren zur herstellung von sekundären metaboliten

Info

Publication number
ATE334203T1
ATE334203T1 AT95931924T AT95931924T ATE334203T1 AT E334203 T1 ATE334203 T1 AT E334203T1 AT 95931924 T AT95931924 T AT 95931924T AT 95931924 T AT95931924 T AT 95931924T AT E334203 T1 ATE334203 T1 AT E334203T1
Authority
AT
Austria
Prior art keywords
microorganism
secondary metabolite
pct
metabolite
producing
Prior art date
Application number
AT95931924T
Other languages
English (en)
Inventor
Michi Egel-Mitani
Henrik Moellgaard
Svend Kaasgaard
Klaus Nyegaard Kristiansen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of ATE334203T1 publication Critical patent/ATE334203T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95931924T 1994-09-28 1995-09-28 Verfahren zur herstellung von sekundären metaboliten ATE334203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111894 1994-09-28

Publications (1)

Publication Number Publication Date
ATE334203T1 true ATE334203T1 (de) 2006-08-15

Family

ID=8101219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95931924T ATE334203T1 (de) 1994-09-28 1995-09-28 Verfahren zur herstellung von sekundären metaboliten

Country Status (7)

Country Link
US (1) US5882883A (de)
EP (1) EP0783581B1 (de)
JP (1) JP3764166B2 (de)
AT (1) ATE334203T1 (de)
AU (1) AU3517895A (de)
DE (1) DE69535126D1 (de)
WO (1) WO1996010084A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495348B1 (en) 1993-10-07 2002-12-17 Regents Of The University Of Minnesota Mitomycin biosynthetic gene cluster
US6524812B1 (en) 1993-10-07 2003-02-25 Regents Of The University Of Minnesota Genes encoding resistance to DNA alkylating agents
EP0870053A4 (de) 1995-12-19 2002-09-11 Univ Minnesota Metabolisches verfahren zur herstellung von polyhydroxyalkanoat-monomer synthasen
US7390619B1 (en) 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
US6541011B2 (en) 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US6451564B1 (en) 1999-07-02 2002-09-17 Massachusetts Institute Of Technology Methods for producing L-isoleucine
US6284483B1 (en) * 1999-10-06 2001-09-04 Board Of Trustees Operating Michigan State University Modified synthetases to produce penicillins and cephalosporins under the control of bicarbonate
JP7755921B2 (ja) 2019-03-29 2025-10-17 味の素株式会社 制御装置、制御方法およびプログラムならびに有機化合物の製造方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200425B1 (de) * 1985-04-22 1991-12-27 Eli Lilly And Company Rekombinante DNS-Expressionsvektoren und DNS-Verbindungen
RU1780542C (ru) * 1985-04-22 1992-12-07 Эли Лилли Энд Компани Способ конструировани рекомбинантной плазмидной ДНК pPS 20, кодирующей изопенициллин-N-синтетазу, способ получени штамма СернаLоSроRIUм асRемоNIUм, обладающего активностью изопенициллин-N-синтетазы
US4892819A (en) * 1985-11-25 1990-01-09 Eli Lilly And Company Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N synthetase from penicillium chrysogenum
EP0260762B1 (de) * 1986-09-16 1994-01-12 Gist-Brocades N.V. Penicilliumtransformanten und Verfahren zu ihrer Herstellung
FI104264B1 (fi) * 1988-08-11 1999-12-15 Dsm Nv Menetelmä sekundääristen metaboliittien tuoton parantamiseksi käyttämällä rykelmöityjä biosynteettisiä geenejä
FI104984B (fi) * 1988-08-11 2000-05-15 Dsm Nv Menetelmä biosynteettisten tai säätelygeenien identifioimiseksi ja käyttämiseksi sekundääristen metaboliittien tuoton parantamiseksi
US5108918A (en) * 1988-08-11 1992-04-28 Gist-Brocades Method for identifying and using biosynthetic genes for enhanced production of secondary metabolites
ATE118042T1 (de) * 1988-12-22 1995-02-15 Lilly Co Eli Rekombinante dna enthaltende expressionsvektoren und für isopenicillin-n-epimerase-(racemase)- aktivität kodierende dns-verbindungen.
FR2642768B1 (fr) * 1989-01-19 1991-05-17 Transgene Sa Procede perfectionne pour l'expression de la biotine dans bacillus sphaericus
IL95766A (en) * 1989-09-27 1996-12-05 Lilly Co Eli Recombinant DNA expression vectors And DNA compounds. Which encode Aspergillus acyltransferase activity
PT97116B (pt) * 1990-03-23 1998-10-30 Gist Brocades Nv Processo para modular a producao de metabolitos secundarios nomeadamente derivados de beta-lactama
KR100227711B1 (ko) * 1991-10-15 1999-12-01 한스 발터 라벤 7-아미노세팔로스포란산 및 7-아미노데아세틸세팔로스포란산 제조를 위한 신규한 생물학적 공정
DE69434023D1 (de) * 1993-07-30 2004-10-28 Dsm Ip Assets Bv Verfahren zur effizienten Herstellung von 7-ADCA via 2-(carboxyethylthio)acetyl-7-ADCA und 3-(carboxymethylthio)propionyl-7-ADCA
US5474912A (en) * 1994-03-03 1995-12-12 Sherman; David H. Method for increasing production of microbial metabolites by genetic engineering

Also Published As

Publication number Publication date
EP0783581A1 (de) 1997-07-16
DE69535126D1 (de) 2006-09-07
JP3764166B2 (ja) 2006-04-05
US5882883A (en) 1999-03-16
EP0783581B1 (de) 2006-07-26
WO1996010084A1 (en) 1996-04-04
AU3517895A (en) 1996-04-19
JPH10506283A (ja) 1998-06-23

Similar Documents

Publication Publication Date Title
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
DE69434079D1 (de) Plasmid zur Herstellung von CRM-Protein und Diphtherie-Toxin
DE69941991D1 (de) Verfahren zur Herstellung von L-Aminosäure
DE69939901D1 (de) Verfahren und materialien zur herstellung von glucosamin
PT1204738E (pt) Processo para a diminuicao da formacao de espuma durante a cultura de um microrganismo
DE69833469D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation
ATE264392T1 (de) Verfahren zur herstellung von d-pantoinsäure und d-pantothensäure oder deren salze
ATE334203T1 (de) Verfahren zur herstellung von sekundären metaboliten
DE69329500D1 (de) Ein verfahren zur herstellung von immunosuppressiva und eine neuartige mikrobielle spezies, die dabei eingesetzt wird
ATE226640T1 (de) Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
ATE427359T1 (de) 5'-inosinsaure herstellender mikroorganismus und verfahren zur herstellung von 5'- inosinsaure unter verwendung desselben
ATE174601T1 (de) Verfahren zur herstellung von bisnoraldehyden aus bisnoralkohol
ATE334195T1 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
WO1998027200A3 (en) Human and mammalian dna replication origin consensus sequences
AU4944996A (en) Dna fragment encoding d-amino acid oxidase
DE59603295D1 (de) Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten
ATE184915T1 (de) Verfahren zur herstellung von vakzinen und ihre verwendung
DE59807569D1 (de) Verfahren zur herstellung von amiden
ATE389710T1 (de) L-glutamine produzierende mikroorganismen und verfahren zur herstellung von l-glutamine unter verwendung derselben
DE68913055D1 (de) Verfahren zur Herstellung von AseI-Restriktionsendonuklease und -methylase.
ATE211716T1 (de) Verfahren zur herstellung von feinverteiltes metallisches kobalt enthaltendem kobalt(ii)-oxid
Egel-Mitani et al. Process for the production of secondary metabolites
KR880010118A (ko) 배지의 당분농도 제어에 의한 외래유전자 발현 제어 방법 및 그에 따른 외래유전자 산물의 생산방법
ATE153384T1 (de) Verfahren zur herstellung von 17alpha-hydroxy-3- methoxy-8,14-seco-1,3,5(10), 9(11)estratetraen-14-on

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties